Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 21/3/2019
SIETES contiene 92697 citas

 1 a 20 de 181 siguiente >>
Presentar resultados
Seleccionar todas
4. Cita con resumen
Naci H, Carter AW, Mossialos E. Why the drug development pipeline is not delivering better medicines. BMJ 2015;351:h5542. [Ref.ID 99639]
5. Cita con resumen
Kesselheim AS, Laggs LR, Sarpatwari A. Experience with the priority review voucher program for drug development. JAMA 2015;314:27 de octubre. [Ref.ID 99526]
6. Cita con resumen
Whitaker R, Cosgrove L, Safra EJ. Corruption impairs discussion on long term use of psychiatric drugs. BMJ 2015;350:h2953. [Ref.ID 99232]
7. Cita con resumen
Anónimo. New cancer research highlights shift In drug development. DIA Daily 2015:2 de junio. [Ref.ID 99121]
8. Cita con resumen
Anderson ML, Chiswell K, Peterson ED, Tasneem A, Topping J, Califf RM. Compliance with results reporting at N Engl J Med 2015;372:1031-9. [Ref.ID 98939]
9. Cita con resumen
Anónimo. Analysis: US share of funding for world’s biomedical research dropping. DIA Daily 2015:14 de enero. [Ref.ID 98723]
10. Cita con resumen
Anónimo. Drug manufacturers race to cure Ebola. DIA Daily 2014:20 de octubre. [Ref.ID 98121]
11. Cita con resumen
Briggs JP, Killen J. Perspectives on complementary and alternative medicine research. JAMA 2013;310:691-2. [Ref.ID 95950]
12.Tiene citas relacionadas Cita con resumen
Califf RM, McCall J, Harrington RA. Assessing research results in the medical literature: trust but verify. JAMA Intern Med 2013;173:1053-5. [Ref.ID 95719]
Hudson KL, Guttmacher AE, Collins FS. In support of SUPPORT - A view from the NIH. N Engl J Med 2013;368:2349-51. [Ref.ID 95697]
15.Tiene citas relacionadas Cita con resumen
Xiao Q, Murphy RA, Houston DK, Harris TB, Chow W-H, Park Y. Dietary and supplemental calcium intake and cardiovascular disease mortality: the National Institutes of Health-AARP Diet and Health Study. JAMA Intern Med 2013;173:639-46. [Ref.ID 95288]
16.Tiene citas relacionadas
Ioannidis JPA. Mega-randomized clinical trials for blockbuster drugs - Reply. JAMA 2013;309:1682-3. [Ref.ID 95285]
17.Tiene citas relacionadas Cita con resumen
Landy DC, Hecht EM. Mega-randomized clinical trials for blockbuster drugs. JAMA 2013;309:1682-3. [Ref.ID 95284]
18.Tiene citas relacionadas Cita con resumen
Ioannidis JPA. Mega-trials for blockbusters. JAMA 2013;309:239-40. [Ref.ID 94781]
19.Tiene citas relacionadas
Naci H, Cylus J, Vandoros S, Sato A, Perampaladas K. Raising the bar for market authorisation of new drugs. BMJ 2012;345:25-8. [Ref.ID 93567]
20.Tiene citas relacionadas Cita con resumen
Light D, Lexchin J. Pharmaceutical R&D. What do we get for all that money?. BMJ 2012;345:22-5. [Ref.ID 93566]
Seleccionar todas
 1 a 20 de 181 siguiente >>